FY2025 EPS Estimate for SBC Medical Group Reduced by Analyst

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Research analysts at Zacks Small Cap decreased their FY2025 EPS estimates for shares of SBC Medical Group in a research report issued on Tuesday, August 19th. Zacks Small Cap analyst M. Marin now expects that the company will post earnings per share of $0.53 for the year, down from their previous estimate of $0.65. The consensus estimate for SBC Medical Group’s current full-year earnings is $5.02 per share.

SBC Medical Group (NASDAQ:SBC) last released its quarterly earnings results on Wednesday, August 13th. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.12). SBC Medical Group had a net margin of 17.71% and a return on equity of 20.76%. The company had revenue of $43.36 million during the quarter, compared to analysts’ expectations of $44.71 million.

Separately, Wall Street Zen lowered shares of SBC Medical Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 16th.

SBC Medical Group Stock Down 2.4%

Shares of NASDAQ:SBC opened at $3.99 on Wednesday. The company has a market capitalization of $413.40 million, a PE ratio of 12.47 and a beta of 1.27. SBC Medical Group has a 1 year low of $2.62 and a 1 year high of $19.50. The company has a debt-to-equity ratio of 0.03, a current ratio of 3.98 and a quick ratio of 3.95. The business has a fifty day moving average price of $4.60 and a two-hundred day moving average price of $4.21.

Institutional Investors Weigh In On SBC Medical Group

Institutional investors have recently added to or reduced their stakes in the company. XTX Topco Ltd purchased a new stake in shares of SBC Medical Group during the second quarter worth about $64,000. New York State Common Retirement Fund bought a new stake in shares of SBC Medical Group in the 2nd quarter worth approximately $104,000. SBI Securities Co. Ltd. raised its holdings in shares of SBC Medical Group by 227.3% during the second quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company’s stock valued at $251,000 after acquiring an additional 37,623 shares in the last quarter. Finally, Geode Capital Management LLC purchased a new stake in SBC Medical Group in the second quarter worth $455,000. Hedge funds and other institutional investors own 60.82% of the company’s stock.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.